We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

56 hedge funds and large institutions have $43.4M invested in ALPS Medical Breakthroughs ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

4.57% less ownership

Funds ownership: 37.38%32.8% (-4.6%)

15% less funds holding

Funds holding: 6656 (-10)

36% less capital invested

Capital invested by funds: $67.5M → $43.4M (-$24.2M)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
56
Holders Change
-10
Holders Change %
-15.15%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
15
Reduced
16
Closed
10
Calls
$1.2M
Puts
Net Calls
+$1.2M
Net Calls Change
-$341K

SBIO Hedge Fund Activity: Q1 2022 in Review

56 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2022, worth a combined $43.4M — down 36% from $67.5M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of SBIO and 3 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 15 added.

The largest buyer was Stifel Financial, adding an estimated $772K. The largest seller was Phoenix Financial, cutting an estimated $4.65M.

  • 56 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2022, down from 66 in Q4 2021.
  • Funds reported $43.4M of ALPS Medical Breakthroughs ETF stock for Q1 2022, down 36% quarter-over-quarter.
  • 3 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2022 and 10 closed out, a net change of -7 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2022 was Stifel Financial, an estimated $772K added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2022 was Phoenix Financial, an estimated $4.65M sold.

Based on aggregated 13F filings for Q1 2022.